Medicare and Medicaid Programs; Announcement of Applications From Hospitals Requesting Waiver for Organ Procurement Service Area, 5599-5601 [2010-2000]
Download as PDF
5599
Federal Register / Vol. 75, No. 22 / Wednesday, February 3, 2010 / Notices
Dated: January 27, 2010.
Elaine Parry,
Director, Office of Program Services.
Reports Clearance Office at (301) 443–
1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
[FR Doc. 2010–2239 Filed 2–2–10; 8:45 am]
BILLING CODE 4162–20–P
Proposed Project: Children’s Hospitals
Graduate Medical Education Payment
Program (CHGME Payment Program)
(OMB No. 0915–0247)—Extension
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA
The CHGME Payment Program was
enacted by Public Law 106–129 and
reauthorized by Public Law 109–307 to
provide Federal support for graduate
medical education (GME) to
freestanding children’s hospitals. This
legislation attempts to provide support
for GME comparable to the level of
Medicare GME support received by
other, non-children’s hospitals. The
legislation indicates that eligible
children’s hospitals will receive
payments for both direct and indirect
medical education. Direct payments are
designed to offset the expenses
associated with operating approved
graduate medical residency training
Number of
respondents
Form name
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
HRSA
99–1
99–1
99–2
99–2
99–3
99–3
99–4
99–5
99–5
Responses
per
respondent
programs and indirect payments are
designed to compensate hospitals for
expenses associated with the treatment
of more severely ill patients and the
additional costs relating to teaching
residents in such programs.
Data are collected on the number of
full-time equivalent residents in
applicant children’s hospitals’ training
programs to determine the amount of
direct and indirect medical education
payments to be distributed to
participating children’s hospitals.
Indirect medical education payments
will also be derived from a formula that
requires the reporting of discharges,
beds, and case mix index information
from participating children’s hospitals.
Hospitals will be requested to submit
such information in an annual
application. Hospitals will also be
requested to submit data on the number
of full-time equivalent residents a
second time during the Federal fiscal
year to participate in the reconciliation
payment process.
The estimated annual burden is as
follows:
Total number
of responses
Hours per
response
Total burden
hours
(Initial) ..............................................................
(Reconciliation) ................................................
(Initial) ..............................................................
(Reconciliation) ................................................
(Initial) ..............................................................
(Reconciliation) ................................................
(Reconciliation) ................................................
(Initial) ..............................................................
(Reconciliation) ................................................
60
60
60
60
60
60
60
60
60
1
1
1
1
1
1
1
1
1
60
60
60
60
60
60
60
60
60
24.67
6
11.33
3.67
0.5
0.5
11
0.33
0.33
1,480.2
360
679.8
220.2
30
30
660
19.8
19.8
Total ..............................................................................
60
........................
60
........................
3,499.8
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov
or by fax to 202–395–6974. Please direct
all correspondence to the ‘‘attention of
the desk officer for HRSA.’’
Dated: January 27, 2010.
Sahira Rafiullah,
Deputy Director, Division of Policy Review
and Coordination.
[FR Doc. 2010–2245 Filed 2–2–10; 8:45 am]
jlentini on DSKJ8SOYB1PROD with NOTICES
BILLING CODE 4165–15–P
VerDate Nov<24>2008
17:47 Feb 02, 2010
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1341–NC]
Medicare and Medicaid Programs;
Announcement of Applications From
Hospitals Requesting Waiver for Organ
Procurement Service Area
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with comment period.
SUMMARY: Two hospitals have requested
waivers of statutory requirements that
would otherwise require the hospitals to
enter into an agreement with their
designated Organ Procurement
Organization (OPO). Both requests were
made in accordance with section
1138(a)(2) of the Social Security Act (the
Jkt 220001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Act). This notice requests comments
from OPOs and the general public for
our consideration in determining
whether we should grant the requested
waivers.
DATES: Comment Date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
April 5, 2010.
ADDRESSES: In commenting, please refer
to file code CMS–1341–NC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
four ways (please choose only one of the
ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the instructions under the ‘‘More Search
Options’’ tab.
E:\FR\FM\03FEN1.SGM
03FEN1
jlentini on DSKJ8SOYB1PROD with NOTICES
5600
Federal Register / Vol. 75, No. 22 / Wednesday, February 3, 2010 / Notices
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–1341–NC, P.O. Box 8010,
Baltimore, MD 21244–1850.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address only: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–1341–NC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
[Note: This zipcode for express mail or
courier delivery only. This zipcode
specifies the agency’s physical location.]
4. By hand or courier. If you prefer,
you may deliver (by hand or courier)
your written comments before the close
of the comment period to either of the
following addresses:
a. For delivery in Washington, DC—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Room 445–G, Hubert
H. Humphrey Building, 200
Independence Avenue, SW.,
Washington, DC 20201.
(Because access to the interior of the
Hubert H. Humphrey Building is not
readily available to persons without
Federal government identification,
commenters are encouraged to leave
their comments in the CMS drop slots
located in the main lobby of the
building. A stamp-in clock is available
for persons wishing to retain a proof of
filing by stamping in and retaining an
extra copy of the comments being filed.)
b. For delivery in Baltimore, MD—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
[Note: This zipcode for express mail or
courier delivery only. This zipcode
specifies the agency’s physical location.]
If you intend to deliver your
comments to the Baltimore address,
please call telephone number (410) 786–
9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses
indicated as appropriate for hand or
courier delivery may be delayed and
received after the comment period.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Mark A. Horney, (410) 786–4554.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
VerDate Nov<24>2008
16:34 Feb 02, 2010
Jkt 220001
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following Web
site as soon as possible after they have
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will also
be available for public inspection as
they are received, generally beginning
approximately 3 weeks after publication
of a document, at the headquarters of
the Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday
through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Background
Organ Procurement Organizations
(OPOs) are not-for-profit organizations
that are responsible for the
procurement, preservation, and
transport of transplantable organs to
transplant centers throughout the
country. Qualified OPOs are designated
by the Centers for Medicare & Medicaid
Services (CMS) to recover or procure
organs in CMS-defined exclusive
geographic service areas, pursuant to
section 371(b)(1)) of the Public Health
Service Act (42 U.S.C. 273(b)(1) and our
regulations at 42 CFR 486.306. Once an
OPO has been designated for an area,
hospitals in that area that participate in
Medicare and Medicaid are required to
work with that OPO in providing organs
for transplant, pursuant to section
1138(a)(1)(C) of the Social Security Act
(the Act) and our regulations at 42 CFR
482.45.
Section 1138(a)(1)(A)(iii) of the Act
provides that a hospital must notify the
designated OPO (for the service area in
which it is located) of potential organ
donors. Under section 1138(a)(1)(C) of
the Act, every participating hospital
must have an agreement to identify
potential donors only with its
designated OPO.
However, section 1138(a)(2)(A) of the
Act provides that a hospital may obtain
a waiver of the above requirements from
the Secretary under certain specified
conditions. A waiver allows the hospital
to have an agreement with an OPO other
than the one initially designated by
CMS, if the hospital meets certain
conditions specified in section
1138(a)(2)(A) of the Act. In addition, the
Secretary may review additional criteria
described in section 1138(a)(2)(B) of the
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Act to evaluate the hospital’s request for
a waiver.
Section 1138(a)(2)(A) of the Act states
that in granting a waiver, the Secretary
must determine that the waiver—(1) is
expected to increase organ donations;
and (2) will ensure equitable treatment
of patients referred for transplants
within the service area served by the
designated OPO and within the service
area served by the OPO with which the
hospital seeks to enter into an
agreement under the waiver. In making
a waiver determination, section
1138(a)(2)(B) of the Act provides that
the Secretary may consider, among
other factors: (1) Cost-effectiveness; (2)
improvements in quality; (3) whether
there has been any change in a
hospital’s designated OPO due to the
changes made in definitions for
metropolitan statistical areas; and (4)
the length and continuity of a hospital’s
relationship with an OPO other than the
hospital’s designated OPO. Under
section 1138(a)(2)(D) of the Act, the
Secretary is required to publish a notice
of any waiver application received from
a hospital within 30 days of receiving
the application, and to offer interested
parties an opportunity to comment in
writing during the 60-day period
beginning on the publication date in the
Federal Register.
The criteria that the Secretary uses to
evaluate the waiver in these cases are
the same as those described above under
sections 1138(a)(2)(A) and (B) of the Act
and have been incorporated into the
regulations at § 486.308(e) and (f).
II. Waiver Request Procedures
In October 1995, we issued a Program
Memorandum (Transmittal No. A–95–
11) detailing the waiver process and
discussing the information hospitals
must provide in requesting a waiver. We
indicated that upon receipt of a waiver
request, we would publish a Federal
Register notice to solicit public
comments, as required by section
1138(a)(2)(D) of the Act.
According to these requirements, we
will review the request and comments
received. During the review process, we
may consult on an as-needed basis with
the Health Resources and Services
Administration’s Division of
Transplantation, the United Network for
Organ Sharing, and our regional offices.
If necessary, we may request additional
clarifying information from the applying
hospital or others. We will then make a
final determination on the waiver
request and notify the hospital and the
designated and requested OPOs.
E:\FR\FM\03FEN1.SGM
03FEN1
Federal Register / Vol. 75, No. 22 / Wednesday, February 3, 2010 / Notices
III. Hospital Waiver Requests
As permitted by § 486.308(e), the
following two hospitals have requested
waivers in order to enter into an
agreement with a designated OPO other
than the OPO designated for the service
area in which the hospital is located:
Valley View Medical Center (Medicare
provider number 03–0117) of Fort
Mohave, Arizona,
Hualapai Mountain Medical Center
(Medicare provider number 03–0128)
of Kingman, Arizona
These hospitals are requesting a
waiver to work with: Donor Network of
Arizona, 201 West Coolidge, Phoenix,
Arizona 85013.
The Hospitals’ Designated OPO is:
Nevada Donor Network Inc., 2085 E.
Sahara Avenue, Las Vegas, Nevada
89104.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; Program No. 93.774, Medicare—
Supplementary Medical Insurance, and
Program No. 93.778, Medical Assistance
Program)
Dated: January 26, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2010–2000 Filed 2–2–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Nathan Shock
Centers.
Date: March 1, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20892.
VerDate Nov<24>2008
16:34 Feb 02, 2010
Jkt 220001
5601
Contact Person: Bita Nakhai, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Bldg., 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20814, 301–402–7701,
nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Genetics.
Date: March 4, 2010.
Time: 7:30 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: William Cruce, PhD,
Scientific Review Officer, National Institute
on Aging, Scientific Review Branch, Gateway
Building 2C–212, 7201 Wisconsin Ave.,
Bethesda, MD 20814, 301–402–7704,
crucew@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Drug
Development for Alzheimer’s Disease.
Date: March 10, 2010.
Time: 12 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703,
Parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Special Emphasis Panel; Repository for
Mouse Models for Cytogenetic Disorders.
Date: February 16, 2010.
Time: 2 p.m. to 3 p.m.
Agenda: To provide concept review of
proposed concept review.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
PhD, Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, 6100 Executive
Boulevard, Room 5b01, Bethesda, MD 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: January 27, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
National Institute of General Medical
Sciences; Notice of Closed Meetings
[FR Doc. 2010–2196 Filed 2–2–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institute of
Child Health and Human Development
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Dated: January 27, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–2197 Filed 2–2–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; ZGM1 MBRS–X (GC).
Date: March 1–2, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency, Bethesda, MD 20814.
Contact Person: John J. Laffan, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
E:\FR\FM\03FEN1.SGM
03FEN1
Agencies
[Federal Register Volume 75, Number 22 (Wednesday, February 3, 2010)]
[Notices]
[Pages 5599-5601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1341-NC]
Medicare and Medicaid Programs; Announcement of Applications From
Hospitals Requesting Waiver for Organ Procurement Service Area
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: Two hospitals have requested waivers of statutory requirements
that would otherwise require the hospitals to enter into an agreement
with their designated Organ Procurement Organization (OPO). Both
requests were made in accordance with section 1138(a)(2) of the Social
Security Act (the Act). This notice requests comments from OPOs and the
general public for our consideration in determining whether we should
grant the requested waivers.
DATES: Comment Date: To be assured consideration, comments must be
received at one of the addresses provided below, no later than 5 p.m.
on April 5, 2010.
ADDRESSES: In commenting, please refer to file code CMS-1341-NC.
Because of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
You may submit comments in one of four ways (please choose only one
of the ways listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the instructions under
the ``More Search Options'' tab.
[[Page 5600]]
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-1341-NC, P.O. Box 8010,
Baltimore, MD 21244-1850.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address only: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-1341-NC, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
[Note: This zipcode for express mail or courier delivery only. This
zipcode specifies the agency's physical location.]
4. By hand or courier. If you prefer, you may deliver (by hand or
courier) your written comments before the close of the comment period
to either of the following addresses:
a. For delivery in Washington, DC--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, Room 445-G, Hubert
H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC
20201.
(Because access to the interior of the Hubert H. Humphrey Building
is not readily available to persons without Federal government
identification, commenters are encouraged to leave their comments in
the CMS drop slots located in the main lobby of the building. A stamp-
in clock is available for persons wishing to retain a proof of filing
by stamping in and retaining an extra copy of the comments being
filed.)
b. For delivery in Baltimore, MD--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, 7500 Security
Boulevard, Baltimore, MD 21244-1850. [Note: This zipcode for express
mail or courier delivery only. This zipcode specifies the agency's
physical location.]
If you intend to deliver your comments to the Baltimore address,
please call telephone number (410) 786-9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses indicated as appropriate for hand
or courier delivery may be delayed and received after the comment
period.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Mark A. Horney, (410) 786-4554.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following Web
site as soon as possible after they have been received: https://www.regulations.gov. Follow the search instructions on that Web site to
view public comments.
Comments received timely will also be available for public
inspection as they are received, generally beginning approximately 3
weeks after publication of a document, at the headquarters of the
Centers for Medicare & Medicaid Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an appointment to view public comments,
phone 1-800-743-3951.
I. Background
Organ Procurement Organizations (OPOs) are not-for-profit
organizations that are responsible for the procurement, preservation,
and transport of transplantable organs to transplant centers throughout
the country. Qualified OPOs are designated by the Centers for Medicare
& Medicaid Services (CMS) to recover or procure organs in CMS-defined
exclusive geographic service areas, pursuant to section 371(b)(1)) of
the Public Health Service Act (42 U.S.C. 273(b)(1) and our regulations
at 42 CFR 486.306. Once an OPO has been designated for an area,
hospitals in that area that participate in Medicare and Medicaid are
required to work with that OPO in providing organs for transplant,
pursuant to section 1138(a)(1)(C) of the Social Security Act (the Act)
and our regulations at 42 CFR 482.45.
Section 1138(a)(1)(A)(iii) of the Act provides that a hospital must
notify the designated OPO (for the service area in which it is located)
of potential organ donors. Under section 1138(a)(1)(C) of the Act,
every participating hospital must have an agreement to identify
potential donors only with its designated OPO.
However, section 1138(a)(2)(A) of the Act provides that a hospital
may obtain a waiver of the above requirements from the Secretary under
certain specified conditions. A waiver allows the hospital to have an
agreement with an OPO other than the one initially designated by CMS,
if the hospital meets certain conditions specified in section
1138(a)(2)(A) of the Act. In addition, the Secretary may review
additional criteria described in section 1138(a)(2)(B) of the Act to
evaluate the hospital's request for a waiver.
Section 1138(a)(2)(A) of the Act states that in granting a waiver,
the Secretary must determine that the waiver--(1) is expected to
increase organ donations; and (2) will ensure equitable treatment of
patients referred for transplants within the service area served by the
designated OPO and within the service area served by the OPO with which
the hospital seeks to enter into an agreement under the waiver. In
making a waiver determination, section 1138(a)(2)(B) of the Act
provides that the Secretary may consider, among other factors: (1)
Cost-effectiveness; (2) improvements in quality; (3) whether there has
been any change in a hospital's designated OPO due to the changes made
in definitions for metropolitan statistical areas; and (4) the length
and continuity of a hospital's relationship with an OPO other than the
hospital's designated OPO. Under section 1138(a)(2)(D) of the Act, the
Secretary is required to publish a notice of any waiver application
received from a hospital within 30 days of receiving the application,
and to offer interested parties an opportunity to comment in writing
during the 60-day period beginning on the publication date in the
Federal Register.
The criteria that the Secretary uses to evaluate the waiver in
these cases are the same as those described above under sections
1138(a)(2)(A) and (B) of the Act and have been incorporated into the
regulations at Sec. 486.308(e) and (f).
II. Waiver Request Procedures
In October 1995, we issued a Program Memorandum (Transmittal No. A-
95-11) detailing the waiver process and discussing the information
hospitals must provide in requesting a waiver. We indicated that upon
receipt of a waiver request, we would publish a Federal Register notice
to solicit public comments, as required by section 1138(a)(2)(D) of the
Act.
According to these requirements, we will review the request and
comments received. During the review process, we may consult on an as-
needed basis with the Health Resources and Services Administration's
Division of Transplantation, the United Network for Organ Sharing, and
our regional offices. If necessary, we may request additional
clarifying information from the applying hospital or others. We will
then make a final determination on the waiver request and notify the
hospital and the designated and requested OPOs.
[[Page 5601]]
III. Hospital Waiver Requests
As permitted by Sec. 486.308(e), the following two hospitals have
requested waivers in order to enter into an agreement with a designated
OPO other than the OPO designated for the service area in which the
hospital is located:
Valley View Medical Center (Medicare provider number 03-0117) of Fort
Mohave, Arizona,
Hualapai Mountain Medical Center (Medicare provider number 03-0128) of
Kingman, Arizona
These hospitals are requesting a waiver to work with: Donor Network
of Arizona, 201 West Coolidge, Phoenix, Arizona 85013.
The Hospitals' Designated OPO is: Nevada Donor Network Inc., 2085
E. Sahara Avenue, Las Vegas, Nevada 89104.
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; Program No. 93.774, Medicare--
Supplementary Medical Insurance, and Program No. 93.778, Medical
Assistance Program)
Dated: January 26, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2010-2000 Filed 2-2-10; 8:45 am]
BILLING CODE 4120-01-P